Kevin Kavanagh
Overview
Explore the profile of Kevin Kavanagh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
163
Citations
3139
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brennan L, Luo X, Mohammed F, Kavanagh K, Elmes R
Chem Sci
. 2025 Feb;
16(9):4075-4084.
PMID: 39906384
Antimicrobial resistance (AMR) - often referred to as a silent pandemic, is at present the most serious threat to medicine, and with constantly emerging resistance to novel drugs, combined with...
2.
Baird R, Yusuf A, Forde L, Pohl K, Kavanagh K, Fitzpatrick F, et al.
Front Immunol
. 2024 Nov;
15:1452393.
PMID: 39493757
The role of neutrophils in host defense involves several cell processes including phagocytosis, degranulation of antimicrobial proteins, and the release of neutrophil extracellular traps (NETs). In turn, dysregulated cell activity...
3.
Grassiri B, Esin S, Piatek M, OFerrall L, Sake J, Griffith D, et al.
Int J Pharm
. 2024 Nov;
667(Pt A):124871.
PMID: 39490551
Azole-resistant Aspergillus fumigatus (A. fumigatus) is an emerging worldwide pathogen. Pulmonary aspergillosis primarily affects severely immunocompromised patients and is also a particularly critical condition for cystic fibrosis (CF) patients. A...
4.
Piatek M, Grassiri B, OFerrall L, Piras A, Batoni G, Esin S, et al.
J Biol Inorg Chem
. 2024 Oct;
29(7-8):719-720.
PMID: 39476189
No abstract available.
5.
Piatek M, Grassiri B, OFerrall L, Piras A, Batoni G, Esin S, et al.
J Biol Inorg Chem
. 2024 Sep;
29(7-8):707-717.
PMID: 39313590
Infections caused by the airborne fungal pathogen, Aspergillus fumigatus, are increasing in severity due to growing numbers of immunocompromised individuals and the increasing incidence of antifungal drug resistance, exacerbating treatment...
6.
Clarke J, Kosanovic D, Kavanagh K, Grogan H, Fitzpatrick D
Microbiol Resour Announc
. 2024 Aug;
13(10):e0057524.
PMID: 39189725
Here, we report the draft genome sequence of strain Kos, isolated from casing soil used during cultivation in Dublin, Ireland. Kos exhibits a suppressive ability toward , , and ,...
7.
Pelliccia S, Russomanno P, Barone S, Mateu B, Alfano A, Miranda M, et al.
J Med Chem
. 2024 Aug;
67(16):14256-14276.
PMID: 39115219
The widespread and irrational use of azole antifungal agents has led to an increase of azole-resistant strains with an urgent need for combination drug therapy, enhancing the treatment efficacy. Here,...
8.
Curtis A, Dobes P, Marciniak J, Hurychova J, Hyrsl P, Kavanagh K
J Med Microbiol
. 2024 Jun;
73(6).
PMID: 38836745
The fungal pathogen can induce prolonged colonization of the lungs of susceptible patients, resulting in conditions such as allergic bronchopulmonary aspergillosis and chronic pulmonary aspergillosis. Analysis of the secretome released...
9.
Curtis A, Binder U, Kavanagh K
Front Fungal Biol
. 2023 Sep;
3:893494.
PMID: 37746216
larvae have become a widely accepted and utilised infection model due to the functional homology displayed between their immune response to infection and that observed in the mammalian innate immune...
10.
OFerrall L, Piatek M, Twamley B, Kavanagh K, OConnor C, Griffith D
Dalton Trans
. 2023 Aug;
52(34):11958-11964.
PMID: 37577980
Ga(III) polypyridyl catecholate complexes of type [Ga(bipy)(O,O)](NO) or [Ga(phen)(O,O)](NO) respectively were readily synthesised on reaction of Ga(NO) in methanol with 1 equivalent of catecholate ligand (2,3-DHBA, 3,4-DHBA, 2,3,4-THBA or CafA)...